Potential therapeutics against neurological disorders: Natural products-based drugs
- PMID: 36060010
- PMCID: PMC9437920
- DOI: 10.3389/fphar.2022.950457
Potential therapeutics against neurological disorders: Natural products-based drugs
Abstract
Neurodegenerative disorders, which are defined by the breakdown of neurons over time, are affecting an increasing number of people. Stroke, Alzheimer's, Parkinson's, Multiple Sclerosis, Migraine, and Amyotrophic Lateral Sclerosis are just a few examples of brain disorders that have no cure. Besides, there is a huge demand for drugs that can cure the diseases mentioned above because the majority of the medications we use to treat them only alleviate diseases. Different neurological disorders have responded satisfactorily to the pharmacological effects of medicinal plants. Despite the numerous multiple types of plants in the world, only a small number of them have been investigated for neurological disorders. As a result, there are many opportunities in this area for further research on plants and their bioactive chemicals. The search for natural therapeutic alternatives that promote faster healing and adverse effects avoidance has gained popularity in recent years. The aim of this mini-review is to explore some natural products that have strong therapeutic effects on neurodegenerative disorders such as Stroke, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Migraine, Amyotrophic Lateral Sclerosis, and others. We have also shown the safety of natural products to improve their appropriate usage in neurological disorders from recent literature.
Keywords: Malnutrition; drugs; natural products; neurological disorders; potential therapeutics.
Copyright © 2022 Rauf and Rahman.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials.Pharmaceutics. 2023 Jan 7;15(1):212. doi: 10.3390/pharmaceutics15010212. Pharmaceutics. 2023. PMID: 36678841 Free PMC article. Review.
-
Natural or Plant Products for the Treatment of Neurological Disorders: Current Knowledge.Curr Drug Metab. 2018;19(5):424-428. doi: 10.2174/1389200218666170710190249. Curr Drug Metab. 2018. PMID: 28699506 Review.
-
Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics.J Clin Med. 2020 Apr 8;9(4):1061. doi: 10.3390/jcm9041061. J Clin Med. 2020. PMID: 32276438 Free PMC article. Review.
-
Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.Int J Mol Sci. 2020 Mar 27;21(7):2316. doi: 10.3390/ijms21072316. Int J Mol Sci. 2020. PMID: 32230811 Free PMC article. Review.
-
Natural Therapeutics in Aid of Treating Alzheimer's Disease: A Green Gateway Toward Ending Quest for Treating Neurological Disorders.Front Neurosci. 2022 May 16;16:884345. doi: 10.3389/fnins.2022.884345. eCollection 2022. Front Neurosci. 2022. PMID: 35651632 Free PMC article. Review.
Cited by
-
Influence of Metabolic, Transporter, and Pathogenic Genes on Pharmacogenetics and DNA Methylation in Neurological Disorders.Biology (Basel). 2023 Aug 22;12(9):1156. doi: 10.3390/biology12091156. Biology (Basel). 2023. PMID: 37759556 Free PMC article.
-
In Vivo Neuropharmacological Effects of Neophytadiene.Molecules. 2023 Apr 14;28(8):3457. doi: 10.3390/molecules28083457. Molecules. 2023. PMID: 37110691 Free PMC article.
-
Exploring the pharmacological mechanisms and therapeutic implications of galangin against neurological disorders.Pharmacol Rep. 2025 Jun 20. doi: 10.1007/s43440-025-00756-z. Online ahead of print. Pharmacol Rep. 2025. PMID: 40540149 Review.
-
Therapeutic potentials of natural products for post-traumatic stress disorder: A focus on epigenetics.Chin Herb Med. 2024 Jul 22;17(2):203-219. doi: 10.1016/j.chmed.2024.07.004. eCollection 2025 Apr. Chin Herb Med. 2024. PMID: 40256720 Free PMC article. Review.
-
Polypyrimidine tract binding protein knockdown reverses depression-like behaviors and cognition impairment in mice with lesioned cholinergic neurons.Front Aging Neurosci. 2023 Apr 27;15:1174341. doi: 10.3389/fnagi.2023.1174341. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37181622 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials